Journal
KARDIOLOGIA POLSKA
Volume 79, Issue 3, Pages 287-293Publisher
POLSKIE TOWARZYSTOWO KARDIOLOGICZNE
DOI: 10.33963/KP.15812
Keywords
patent ductus arteriosus; percutaneous intervention; treatment outcome
Categories
Funding
- Medical University of Silesia [KNW-2-K15/D/8/N]
Ask authors/readers for more resources
Transcatheter closure of patent ductus arteriosus with various devices is safe and effective, with high success rates and significant outcomes after 1 year. ADO II AS has replaced coils as the preferred device for closing small-to-moderate PDA.
BACKGROUND Transcatheter patent ductus arteriosus (PDA) closure has become the first-choice method of treatment in the majority of patients. However, device selection poses a challenge. AIMS This study aimed to analyze periprocedural and 1-year outcomes of PDA transcatheter closure performed with different devices throughout a 25-year time period in a single center. METHODS All 1036 patients who underwent transcatheter PDA closure between 1993 and 2020 were included in retrospective analysis. Various devices were used: the Rashkind device ( RD; n = 25), coils (n = 469), nitinol duct occluders type I (DO I; n = 300), type II (n = 32), type II additional sizes (ADO II AS; n = 209), as well as off-label devices: vascular plugs and atrial septal and muscular ventricular septal defect occluders (n = 17). Data on 24-hour and 1-year follow-up were available for 100% and 78.9% of the study patients, respectively. RESULTS The procedure was successful in 98.6% of the study patients, with a major complication rate of 0.2%. Complete PDA closure after a year was observed in 81.8% of the patients treated with RD, 93.7% of those with coils, and 100% of those with duct occluders. There were no differences between Amplatzer DO I (n = 159) and its DO I copies manufactured in China (n = 141) with regard to success, efficacy, and complication rates. Recently, ADO II AS has replaced coils and become the preferred device to close small-to-moderate PDA. CONCLUSIONS Transcatheter PDA closure with all types of nitinol duct occluders is safe and effective, with no residual shunting at 1-year follow-up. Due to higher efficacy, ADO II AS has replaced coils in the treatment of smaller PDA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available